Oral Mucosal Lesions Among Smokers in an Egyptian Population.

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT03299595
Collaborator
(none)
824
1
19.9
41.4

Study Details

Study Description

Brief Summary

This cross-sectional study will assess the prevalence of oral changes among smokers in an Egyptian cohort (patients attending to the hospital of Faculty of Dentistry - Cairo University), aiming that this study can serve as a baseline for future studies with the goal of finding ways to improve oral health and increase awareness of the hazards of smoking in Egypt

Condition or Disease Intervention/Treatment Phase
  • Other: printed questionnaire

Detailed Description

The participants will be selected from the pool of the Clinics of Oral Medicine, Periodontology and Diagnosis Department and the Diagnostic center, Faculty of Dentistry - Cairo University. For each eligible participant, a full history will be obtained according to a questionnaire followed by thorough clinical examination.

Study Design

Study Type:
Observational
Actual Enrollment :
824 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Prevalence of Oral Mucosal Lesions Among Smokers in an Egyptian Cohort: A Hospital-based Cross-Sectional Study (II)
Actual Study Start Date :
Nov 1, 2017
Actual Primary Completion Date :
Mar 30, 2019
Actual Study Completion Date :
Jun 30, 2019

Outcome Measures

Primary Outcome Measures

  1. oral mucosal lesions [one year]

    Identifying and recording oral mucosal lesions

Secondary Outcome Measures

  1. Oral health-related quality of life (OH-QoL) evaluation [one year]

    using Oral Health Impact Profile (OHIP)

  2. histopathological evaluation [one year]

    light microscope

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Gender: males and females.

  • Age: all age groups.

  • Smokers.

  • Individuals who agreed to sign the informed consent.

Exclusion Criteria:
  • Individuals suffering from any systemic disease.

  • Individuals on medications.

  • Non-Egyptians.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Dentistry Cairo Egypt 11728

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alaa Shousha, resident, Cairo University
ClinicalTrials.gov Identifier:
NCT03299595
Other Study ID Numbers:
  • CEBC-CU-2017-08-01
First Posted:
Oct 3, 2017
Last Update Posted:
Jan 8, 2021
Last Verified:
Jan 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 8, 2021